We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients

By MedImaging International staff writers
Posted on 06 Feb 2026
Image: A standard cardiac MRI could provide critical oxygen measurements without invasive catheter procedures (Photo courtesy of 123RF)
Image: A standard cardiac MRI could provide critical oxygen measurements without invasive catheter procedures (Photo courtesy of 123RF)

Heart failure patients often require right heart catheterization to assess how severely their heart is struggling to pump blood, a procedure that involves inserting a tube into the heart to measure blood oxygen levels. While clinically valuable, the test is invasive, uncomfortable, and carries risks, particularly for older, frail, or critically ill patients. Researchers have now shown that the same vital information can be estimated safely and non-invasively using a routine heart MRI scan.

In collaborative research led by the University of East Anglia (Norwich, UK), the team focused on replacing invasive catheter-based oxygen measurements with data derived from standard cardiac MRI. Using a commonly available MRI technique known as T2 mapping, they developed a formula that estimates how much oxygen remains in blood returning to the heart, a key marker of heart failure severity.

The method works by exploiting how blood with different oxygen levels behaves in a magnetic field. By measuring subtle changes in MRI signals, the researchers were able to predict mixed venous oxygen saturation without inserting catheters or drawing blood. Importantly, the technique requires no additional hardware, no contrast dye, and adds only seconds to a routine cardiac MRI scan.

The researchers first validated the approach in 30 patients by directly comparing MRI-based estimates with catheter readings, finding close agreement between the two. They then applied the method to 628 patients with newly diagnosed heart failure and followed them for nearly three years. Patients with healthier MRI-derived oxygen readings were significantly less likely to die or be hospitalized.

The findings, published in JACC Advances, show that MRI-based oxygen measurement remained a strong predictor of outcomes even after accounting for age, other illnesses, and overall heart function. This suggests the method could be used to assess risk, guide treatment decisions, and enable safer repeat monitoring over time. Researchers believe the approach could spare thousands of patients from invasive testing and plan further studies to confirm its usefulness across different hospitals and patient groups.

“One of the most important markers in advanced heart failure is how much oxygen is left in blood returning to the heart,” said Professor Pankaj Garg, lead author of the study. “Our study shows this can now be estimated non-invasively from a standard heart MRI, potentially transforming how we assess and monitor heart failure.”

Related Links:
University of East Anglia

Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Breast Localization System
MAMMOREP LOOP
Digital X-Ray Detector Panel
Acuity G4
Biopsy Software
Affirm® Contrast

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.